Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study
dc.contributor.author | Arason, V A | |
dc.contributor.author | Kristinsson, K G | |
dc.contributor.author | Sigurdsson, J A | |
dc.contributor.author | Stefansdottir, G | |
dc.contributor.author | Mölstad, S | |
dc.contributor.author | Gudmundsson, S | |
dc.date.accessioned | 2010-09-29T11:42:10Z | |
dc.date.available | 2010-09-29T11:42:10Z | |
dc.date.issued | 1996-08-17 | |
dc.date.submitted | 2010-09-29 | |
dc.identifier.citation | BMJ. 1996, 313(7054):387-91 | en |
dc.identifier.issn | 0959-8138 | |
dc.identifier.pmid | 8761224 | |
dc.identifier.uri | http://hdl.handle.net/2336/112022 | |
dc.description | To access publisher full text version of this article. Please click on the hyperlink in Additional Links field | en |
dc.description.abstract | OBJECTIVE: To study the correlation of antimicrobial consumption with the carriage rate of penicillin resistant and multiresistant pneumococci in children. DESIGN: Cross sectional and analytical prevalence study. SETTING: Five different communities in Iceland. MAIN OUTCOME MEASURE: Prevalence of nasopharyngeal carriage of penicillin resistant pneumococci in children aged under 7 years in relation to antibiotic use as determined by information from parents, patient's records, and total sales of antimicrobials from local pharmacies in four study areas. RESULTS: Total antimicrobial sales for children (6223 prescriptions) among the four areas for which data were available ranged from 9.6 to 23.2 defined daily doses per 1000 children daily (1.1 to 2.6 courses yearly per child). Children under 2 consumed twice as much as 2-6 year olds (20.5 v 10.9 defined daily doses per 1000 children daily). Nasopharyngeal specimens were obtained from 919 children, representing 15-38% of the peer population groups in the different areas. Pneumococci were carried by 484 (52.7%) of the children, 47 (9.7%) of the isolates being resistant to penicillin or multiresistant. By multivariate analysis age (< 2 years), area (highest antimicrobial consumption), and individual use of antimicrobials significantly influenced the odds of carrying penicillin resistant pneumococci. By univariate analysis, recent antimicrobial use (two to seven weeks) and use of co-trimoxazole were also significantly associated with carriage of penicillin resistant pneumococci. CONCLUSIONS: Antimicrobial use, with regard to both individual use and total antimicrobial consumption in the community, is strongly associated with nasopharyngeal carriage of penicillin resistant pneumococci in children. Control measures to reduce the prevalence of penicillin resistant pneumococci should include reducing the use of antimicrobials in community health care. | |
dc.language.iso | en | en |
dc.publisher | British Medical Association | en |
dc.relation.url | http://www.bmj.com/content/313/7054/387.abstract | en |
dc.subject.mesh | Age Factors | en |
dc.subject.mesh | Anti-Bacterial Agents | en |
dc.subject.mesh | Carrier State | en |
dc.subject.mesh | Child | en |
dc.subject.mesh | Child, Preschool | en |
dc.subject.mesh | Cross-Sectional Studies | en |
dc.subject.mesh | Female | en |
dc.subject.mesh | Humans | en |
dc.subject.mesh | Iceland | en |
dc.subject.mesh | Infant | en |
dc.subject.mesh | Infant, Newborn | en |
dc.subject.mesh | Male | en |
dc.subject.mesh | Multivariate Analysis | en |
dc.subject.mesh | Nasopharyngeal Diseases | en |
dc.subject.mesh | Nasopharynx | en |
dc.subject.mesh | Penicillin Resistance | en |
dc.subject.mesh | Pneumococcal Infections | en |
dc.subject.mesh | Prevalence | en |
dc.subject.mesh | Residence Characteristics | en |
dc.subject.mesh | Streptococcus pneumoniae | en |
dc.subject.mesh | Trimethoprim-Sulfamethoxazole Combination | en |
dc.title | Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study | en |
dc.type | Article | en |
dc.contributor.department | Department of Family Medicine, Sólvangur Health Centre, University of Iceland, Hafnarfjördur, Iceland. | en |
dc.identifier.journal | BMJ (Clinical research ed.) | en |
html.description.abstract | OBJECTIVE: To study the correlation of antimicrobial consumption with the carriage rate of penicillin resistant and multiresistant pneumococci in children. DESIGN: Cross sectional and analytical prevalence study. SETTING: Five different communities in Iceland. MAIN OUTCOME MEASURE: Prevalence of nasopharyngeal carriage of penicillin resistant pneumococci in children aged under 7 years in relation to antibiotic use as determined by information from parents, patient's records, and total sales of antimicrobials from local pharmacies in four study areas. RESULTS: Total antimicrobial sales for children (6223 prescriptions) among the four areas for which data were available ranged from 9.6 to 23.2 defined daily doses per 1000 children daily (1.1 to 2.6 courses yearly per child). Children under 2 consumed twice as much as 2-6 year olds (20.5 v 10.9 defined daily doses per 1000 children daily). Nasopharyngeal specimens were obtained from 919 children, representing 15-38% of the peer population groups in the different areas. Pneumococci were carried by 484 (52.7%) of the children, 47 (9.7%) of the isolates being resistant to penicillin or multiresistant. By multivariate analysis age (< 2 years), area (highest antimicrobial consumption), and individual use of antimicrobials significantly influenced the odds of carrying penicillin resistant pneumococci. By univariate analysis, recent antimicrobial use (two to seven weeks) and use of co-trimoxazole were also significantly associated with carriage of penicillin resistant pneumococci. CONCLUSIONS: Antimicrobial use, with regard to both individual use and total antimicrobial consumption in the community, is strongly associated with nasopharyngeal carriage of penicillin resistant pneumococci in children. Control measures to reduce the prevalence of penicillin resistant pneumococci should include reducing the use of antimicrobials in community health care. |